During the past decade, Studienzentrum Klinikum Nuernberg conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Studienzentrum Klinikum Nuernberg" are "Major Depressive Disorder" (2 trials). Many other conditions were trialed in "Studienzentrum Klinikum Nuernberg" in a lesser frequency.

Most popular intervention types in "Studienzentrum Klinikum Nuernberg" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Antidepressant + Placebo" (1 trials), "Antidepressant + SPD489 (Lisdexamfetamine dimesylate )" (1 trials) and "SPD489 (Lisdexamfetamine dimesylate) + Antidepressant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Studienzentrum Klinikum Nuernberg" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Studienzentrum Klinikum Nuernberg". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Studienzentrum Klinikum Nuernberg, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Studienzentrum Klinikum Nuernberg, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".